EUVIMEDEUVIMED entdecken
Crossref

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis‐ and Angiogenesis‐Related Proteins

Ecem Kaya-Sezginer iD, Filiz Bakar-Ates iD

Fundamental & Clinical Pharmacology · 2026-07 · 40 (4)

DOI: 10.1111/fcp.70104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 26.06.2026. Verfasst von Ecem Kaya-Sezginer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Apoptosis, Probucol, Neovascularization, Pathologic. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer remains one of the leading causes of cancer‐related mortality worldwide, highlighting the need for novel therapeutic agents with multitarget anticancer activity. Probucol is a phenolic compound with well‐established antioxidant and anti‐inflammatory properties; however, its effects on colorectal cancer cells have not been fully elucidated. The present study aimed to investigate the antitumor effects of probucol on SW480 human colorectal cancer cells and to explore the underlying molecular mechanisms focusing on cell cycle, apoptosis‐, and angiogenesis‐associated proteins. SW480 cells treated with probucol were subjected to MTT analysis. Cell cycle distribution and apoptosis were evaluated using cell cycle assay, Annexin V binding assay, and multicaspase activity assay. Apoptosis‐ and angiogenesis‐related protein expression was analyzed by western blot, matrix metalloproteinase‐9 (MMP‐9) mRNA expression was quantified by real‐time PCR. Probucol significantly reduced cell viability in a dose‐dependent manner and induced cell cycle arrest at the G0/G1 phase. Treatment with probucol markedly increased early and late apoptotic cell populations and enhanced multicaspase activation. The upregulation of pro‐apoptotic Bax protein was accompanied by downregulation of antiapoptotic Bcl‐2. In addition, probucol significantly suppressed the expression of angiogenesis‐associated proteins, including vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) and also decreased MMP‐9 mRNA expression, indicating a potential antimetastatic effect. These findings demonstrate that probucol exerts significant anticancer effects on colorectal cancer cells by inhibiting cell proliferation, inducing apoptosis, and suppressing angiogenesis‐ and metastasis‐related molecular markers. Probucol may represent a promising candidate for further investigation as a potential multitarget agent in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsApoptosisProbucolNeovascularization, PathologicAntineoplastic AgentsHumansCell Line, TumorMatrix Metalloproteinase 9Cell SurvivalDose-Response Relationship, DrugCell ProliferationCell Cycle

Stichwörter der Autor:innen

SW480angiogenesisapoptosiscolorectal cancerprobucolproliferation

Substanzen

ProbucolMatrix Metalloproteinase 9Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Türkiye.

ORCID-Profile: Ecem Kaya-Sezginer, Filiz Bakar-Ates

Zitieren

APA

Kaya-Sezginer, E., & Bakar-Ates, F. (2026). Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis‐ and Angiogenesis‐Related Proteins. Fundamental & Clinical Pharmacology, 40(4). https://doi.org/10.1111/fcp.70104

Vancouver

Kaya-Sezginer E, Bakar-Ates F. Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis‐ and Angiogenesis‐Related Proteins. Fundamental & Clinical Pharmacology. 2026;40(4). doi:10.1111/fcp.70104

BibTeX
@article{KayaSezginer2026,
  author = {Kaya-Sezginer, Ecem and Bakar-Ates, Filiz},
  title = {Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis‐ and Angiogenesis‐Related Proteins},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2026},
  volume = {40},
  number = {4},
  doi = {10.1111/fcp.70104}
}
Kostenlos starten →